Literature DB >> 19874185

Evaluation of a dengue IgG indirect enzyme-linked immunosorbent assay and a Japanese encephalitis IgG indirect enzyme-linked immunosorbent assay for diagnosis of secondary dengue virus infection.

Shingo Inoue1, Maria T G Alonzo, Yae Kurosawa, Cynthia A Mapua, Joyce D Reyes, Efren M Dimaano, Maria Theresa P Alera, Mariko Saito, Kazunori Oishi, Futoshi Hasebe, Ronald R Matias, Filipinas F Natividad, Kouichi Morita.   

Abstract

To establish a new method for the diagnosis of dengue secondary infection, 187 serum samples from the patients with dengue secondary infection, 40 serum samples from the patients with dengue primary infection, and 44 serum samples from the healthy volunteers were tested using the dengue IgG indirect enzyme-linked immunosorbent assay (DEN IgG ELISA). The results of the test were compared with those from the dengue hemagglutination inhibition (DEN HI) test, which has been recommended as the gold standard by the World Health Organization (WHO, 1997). Japanese encephalitis IgG indirect ELISA (JE IgG ELISA) was also performed to measure anti-flavivirus IgG, which cross-reacts with the Japanese encephalitis virus, to test the possibility of an alternative to DEN IgG ELISA. The results of DEN IgG and JE IgG ELISAs were highly correlated with those of the DEN HI test. In the DEN IgG ELISA, a titer of 1:29,000 was the cut-off value for the diagnosis of dengue secondary infection (91.5% accuracy [95% confidence interval, CI], 90.9% sensitivity [95%CI], and 92.9% specificity [95%CI]). A titer of 1:52,000 was the cut-off value for dengue secondary infection using JE IgG ELISA (95.6% accuracy [95%CI], 98.9% sensitivity [95%CI], and 88.1% specificity [95%CI]). In conclusion, this study confirmed that the results of both DEN IgG and JE IgG ELISAs were highly correlated with the results of DEN HI test. Thus, these ELISAs are simple, rapid, sensitive, and quantitative tests that can be used in the determination of dengue secondary infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19874185     DOI: 10.1089/vbz.2008.0153

Source DB:  PubMed          Journal:  Vector Borne Zoonotic Dis        ISSN: 1530-3667            Impact factor:   2.133


  21 in total

1.  An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.

Authors:  Akane Urakami; Mya Myat Ngwe Tun; Meng Ling Moi; Atsuko Sakurai; Momoko Ishikawa; Sachiko Kuno; Ryuji Ueno; Kouichi Morita; Wataru Akahata
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

2.  Detection of Zika Virus Infection in Myanmar.

Authors:  Mya Myat Ngwe Tun; Aung Kyaw Kyaw; Saw Wut Hmone; Shingo Inoue; Corazon C Buerano; Aung Min Soe; Meng Ling Moi; Daisuke Hayasaka; Hlaing Myat Thu; Futoshi Hasebe; Kyaw Zin Thant; Kouichi Morita
Journal:  Am J Trop Med Hyg       Date:  2018-01-18       Impact factor: 2.345

3.  Detection of Chikungunya Virus in Nepal.

Authors:  Basu Dev Pandey; Biswas Neupane; Kishor Pandey; Mya Myat Ngwe Tun; Kouichi Morita
Journal:  Am J Trop Med Hyg       Date:  2015-07-20       Impact factor: 2.345

4.  Serological Evidence of Zika Virus Infection in Febrile Patients and Healthy Blood Donors in Sabah, Malaysian Borneo, 2017-2018.

Authors:  Mya Myat Ngwe Tun; Daisuke Mori; Shahnaz Binti Sabri; Omar Kugan; Saliz Binti Shaharom; Jecelyn John; Aung Min Soe; Khine Mya Nwe; Jiloris Frederick Dony; Shingo Inoue; Kouichi Morita; Kamruddin Ahmed
Journal:  Am J Trop Med Hyg       Date:  2021-11-22       Impact factor: 2.345

5.  Clinical, Virological, and Cytokine Profiles of Children Infected with Dengue Virus during the Outbreak in Southern Vietnam in 2017.

Authors:  Mya Myat Ngwe Tun; Thi Thu Thuy Nguyen; Tsuyoshi Ando; Shyam Prakash Dumre; Aung Min Soe; Corazon C Buerano; Minh Tuan Nguyen; Nguyen Thanh Nhan Le; Van Quang Pham; Thanh Hung Nguyen; Thi Quynh Mai Le; Kouichi Morita; Futoshi Hasebe
Journal:  Am J Trop Med Hyg       Date:  2020-06       Impact factor: 2.345

6.  Clinical, virological and epidemiological characterization of dengue outbreak in Myanmar, 2015.

Authors:  A K Kyaw; M M Ngwe Tun; M L Moi; T Nabeshima; K T Soe; S M Thwe; A A Myint; K T T Maung; W Aung; D Hayasaka; C C Buerano; K Z Thant; K Morita
Journal:  Epidemiol Infect       Date:  2017-04-17       Impact factor: 4.434

7.  Retrospective seroepidemiological study of chikungunya infection in South Asia, Southeast Asia and the Pacific region.

Authors:  M M Ngwe Tun; S Inoue; K Z Thant; N Talemaitoga; A Aryati; E M Dimaano; R R Matias; C C Buerano; F F Natividad; W Abeyewickreme; N T T Thuy; L T Q Mai; F Hasebe; D Hayasaka; K Morita
Journal:  Epidemiol Infect       Date:  2016-03-28       Impact factor: 4.434

8.  First isolation of dengue virus from the 2010 epidemic in Nepal.

Authors:  Basu D Pandey; Takeshi Nabeshima; Kishor Pandey; Saroj P Rajendra; Yogendra Shah; Bal R Adhikari; Govinda Gupta; Ishan Gautam; Mya M N Tun; Reo Uchida; Mahendra Shrestha; Ichiro Kurane; Kouichi Morita
Journal:  Trop Med Health       Date:  2013-08-20

9.  Emergence of a Novel Dengue Virus 3 (DENV-3) Genotype-I Coincident with Increased DENV-3 Cases in Yangon, Myanmar between 2017 and 2019.

Authors:  Aung Min Soe; Mya Myat Ngwe Tun; Takeshi Nabeshima; Theingi Win Myat; Moh Moh Htun; Htin Lin; Nang Sarm Hom; Shingo Inoue; Khine Mya Nwe; Lynn Pa Pa Aye; Mizuki Fukuta; Kyaw Zin Thant; Futoshi Hasebe; Kouichi Morita; Sujan Shresta; Hlaing Myat Thu; Meng Ling Moi
Journal:  Viruses       Date:  2021-06-16       Impact factor: 5.048

10.  Effectiveness of the SA 14-14-2 Live-Attenuated Japanese Encephalitis Vaccine in Myanmar.

Authors:  Mya Myat Ngwe Tun; Aung Kyaw Kyaw; Khine Mya Nwe; Shingo Inoue; Kyaw Zin Thant; Kouichi Morita
Journal:  Vaccines (Basel)       Date:  2021-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.